A Legacy of Innovation: The Max Noureddine Exit Interview, Part One
December 30, 2010 · Leave a comment
Prateek Peres-da-Silva, an intern at Thought Leader Select and student at the University of North Carolina’s Kenan-Flagler Business School, recently sat down with Dr. Maher “Max” Noureddine, Thought Leader Select’s departing chief scientific officer, to discuss his achievements at the company, as well as his vision for the non-profit he is launching to improve the professional lives of health care providers. Peres-da-Silva is a junior at UNC, double-majoring in business and biochemistry.
Prateek Peres-da-Silva: Good morning, Max. I’d like to hear some of your thoughts on your time at Thought Leader Select. Can you share a little about yourself and your role with the company?
Max Noureddine: Yes, Prateek. In terms of my training, I am a molecular geneticist with experience in biomedical research. I did my doctoral training in the genetics of cell cycle regulation, and then focused on the molecular genetics of neurodegenerative disorders as well as cancer. I joined Thought Leader Select in the fall of 2007 as the chief scientific officer and director of product development. In collaboration with an outstanding team at the company, I became responsible for the development and execution of the company’s line of competitive services and solutions in the area of key opinion leader assessments and profiling in particular, and in pharmaceutical consulting in general. As CSO, I am responsible for validating the ... read more »
TAGS: 
biomedical research biopharmaceutical biotechnology cancer cell cycle regulation health care providers impact mapping Kenan-Flagler Business School key opinion leaders KOL engagement KOL identification KOL profiling KOLs Maher Noureddine molecular genetics neurodegenerative disorders pharmaceutical Prateek Peres-da-Silva product development Thought Leader Index Thought Leader Select Thought Leader Select Innovation Lab UNC value mapping